Exogenous Methicillin-Resistant <italic>Staphylococcus aureus</italic> Endophthalmitis is Caused by Multidrug-Resistant Lineages that are Associated with Poor Outcomes.

PurposeMethodsResultsConclusionTo investigate the genomic epidemiology of methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) endophthalmitis and correlate it with the presenting clinical features and outcomes.Nine patients presenting with MRSA endophthalmitis from 2014 to 2022 were included. Phenotypic and genomic tests were used for strain characterization. Demographics, clinical presentation, treatment and outcomes were reviewed.The MRSA population was dominated by multidrug-resistant (MDR) strains within the clonal complex 5 (CC5) carrying an SCC<italic>mec</italic> type II genetic element (USA100-like strains). These strains carried genes that confer resistance to five antibiotic classes, in addition to mutations in topoisomerase genes (<italic>gyrA</italic> and <italic>parC</italic>) that resulted in resistance to all fluoroquinolones tested. Patients were mostly male (56%), with a median age of 82.7 years, and most had no recent history of extensive healthcare exposure. All cases were exogenous following ocular surgery (67%) or intravitreal injection (33%). The main exam findings were visual acuity ≤ hand motion, hypopyon (89%), and vitreous opacity (89%). Five patients (56%) showed improvement in visual acuity at 1 month following presentation, three (33%) at 3 months, and two (22%) at 6 months. Complications included evisceration (<italic>n</italic> = 1) and phthisis (<italic>n</italic> = 1). Patients who had pars plana vitrectomy within 48 hours of presentation had better clinical outcomes compared to those who did not.Exogenous MRSA endophthalmitis is caused by MDR strains that resemble the hospital-acquired lineage USA100. These strains cause severe endophthalmitis in patients with no recent hospital/healthcare exposure. [ABSTRACT FROM AUTHOR]